Development of Stimuli-Responsive Chitosan/ZnO NPs Transdermal Systems for Controlled Cannabidiol Delivery.
cannabidiol
chitosan
drug delivery
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
08 Jan 2021
08 Jan 2021
Historique:
received:
30
11
2020
revised:
31
12
2020
accepted:
04
01
2021
entrez:
13
1
2021
pubmed:
14
1
2021
medline:
14
1
2021
Statut:
epublish
Résumé
One of the most common neurological diseases is epilepsy, which not only negatively affects the quality of people's life but also may lead to life-threatening situations when its symptoms such as seizures cannot be controlled medically. A very serious problem to be overcame is the untreatable form of this disease, which cannot be cured by any currently available medicines. Cannabidiol, which is a natural product obtained from
Identifiants
pubmed: 33435623
pii: polym13020211
doi: 10.3390/polym13020211
pmc: PMC7826855
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Narodowe Centrum Nauki
ID : 2017/26/D/ST8/00979
Références
Eur J Pharm Biopharm. 2012 Aug;81(3):463-9
pubmed: 22561955
Clin Pharmacokinet. 2003;42(4):327-60
pubmed: 12648025
Epilepsy Behav. 2019 Jun;95:10-17
pubmed: 31003195
Polymers (Basel). 2020 Jul 08;12(7):
pubmed: 32650625
Dalton Trans. 2013 Sep 21;42(35):12554-68
pubmed: 23652237
Colloids Surf B Biointerfaces. 2020 Oct;194:111170
pubmed: 32521459
Int J Mol Sci. 2020 Nov 23;21(22):
pubmed: 33238607
AAPS PharmSciTech. 2019 Jan 10;20(2):69
pubmed: 30631984
Iran J Pharm Res. 2011 Summer;10(3):553-8
pubmed: 24250388
Int J Pharm. 2017 Dec 20;534(1-2):190-194
pubmed: 29038062
J Control Release. 2003 Dec 12;93(3):377-87
pubmed: 14644587
Drug Dev Ind Pharm. 2010 Sep;36(9):1088-97
pubmed: 20545522
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):139-154
pubmed: 28861514
Phytother Res. 2009 May;23(5):597-602
pubmed: 18844286
Int J Biol Macromol. 2020 Dec 1;164:4532-4546
pubmed: 32941908
Epilepsy Behav. 2017 May;70(Pt B):341-348
pubmed: 28188044
Int J Biol Macromol. 2017 Dec;105(Pt 3):1636-1643
pubmed: 28167105
Pharmaceutics. 2017 Nov 20;9(4):
pubmed: 29156634
Enzyme Microb Technol. 2001 Apr 5;28(6):550-559
pubmed: 11267651
Epilepsy Behav. 2020 Oct;111:107299
pubmed: 32759071
Neurol Clin Pract. 2011 Dec;1(1):14-23
pubmed: 23634355
Sci Rep. 2016 Apr 18;6:24596
pubmed: 27086569
Nanomaterials (Basel). 2018 Apr 23;8(4):
pubmed: 29690644
Eur J Med Chem. 2020 Apr 15;192:112163
pubmed: 32109623
Biomolecules. 2020 Nov 19;10(11):
pubmed: 33228239
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111544
pubmed: 33255096
Int J Biol Macromol. 2021 Jan 15;167:807-833
pubmed: 33144253
Int J Biol Macromol. 2018 Apr 1;109:273-286
pubmed: 29248555
Drug Dev Ind Pharm. 2004 Apr;30(4):397-404
pubmed: 15132182
Adv Drug Deliv Rev. 2018 Mar 1;127:35-45
pubmed: 28867296
Molecules. 2020 Sep 04;25(18):
pubmed: 32899678
J Biomater Sci Polym Ed. 2020 Feb;31(3):350-375
pubmed: 31766978
Molecules. 2020 Nov 07;25(21):
pubmed: 33171772
Epilepsia. 2014 Jun;55(6):791-802
pubmed: 24854329